Recent News

• 11.05.2026 - BD Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
• 11.05.2026 - BD Board Increases Dividend for 55th Consecutive Year, Authorizes 10 Million Additional Share Repurchases
• 11.04.2026 - BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
• 11.04.2026 - BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
• 10.28.2026 - BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
• 10.28.2026 - BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
• 10.08.2026 - BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026
• 10.08.2026 - BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide
• 10.08.2026 - BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide
• 10.07.2026 - BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Recent Filings

• 11.05.2026 - 144 Report of proposed sale of securities
• 11.05.2026 - 8-K Current report
• 10.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.26.2026 - 144 Report of proposed sale of securities
• 09.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.28.2026 - 144 Report of proposed sale of securities
• 09.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2026 - 144 Report of proposed sale of securities
• 08.24.2026 - 4 Statement of changes in beneficial ownership of securities